Abstract
Activation of helper T cell has been implicated in a number of autoimmune diseases including rheumatoid arthritis. The underlying mechanism that initiates and promotes disease progression remains unclear, but it is apparent that helper T cells and autoantigens play prominentroles. Identification of the autoantigens has proven to be extremely difficult, and therefore strategies for promoting tolerance induction remain limited. Since autoimmune diseases are closely associated with specific major histocompatibility complex class II molecules such as HLA-DR4, the use of competitor peptides is an alternative strategy. A limitation of competitor peptides, however, is that they are ineffective in vivo. In the studies presented here, we demonstrate that coupling competitor peptides to a cell-surface receptor ligand, transferrin, enhances their ability to block helper T cell responses using the DO11.10 transgenic mouse as our model system.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Svejgaard A, Platz P, Ryder LP: HLA and disease 1982—a survey. Immunol Rev 1983;70:193–218.
Werdelin O: Chemically related antigens complete for presentation by accessory cells to T cells. J Immunol 1982;129:1883–1891.
Babbitt BP, Matsueda G, Haber E, Unanue ER, Allen PM: Antigenic competition at the level of peptidela binding. Proc Natl Acad Sci USA 1986;83:4509–4513.
Adorini L, Muller S, Cardinaux F, Lehmann PV, Falcioni F, Nagy ZA: In vivo competition between self peptides and foreign antigens in T-cell activation. Nature 1988;334:623–625.
Lorenz RG, Blum JS, Allen PM: Constitutive competition by self proteins for antigen presentation can be overcome by receptor-enhanced uptake. J Immunol 1990; 144:1600–1606.
Lanzavecchia A: Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 1990;8: 773–793.
Legge KL, Min B, Potter NT, Zaghouani H: Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by asynthetic peptide or proteins requiring endocytic processing. J. Exp Med 1997;185: 1043–1053.
Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, Steinman RM, Nussenzweig MC: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001;194:769–779.
Lock C, Smilek D, Gautam A, Vaysburd M, Dwivedy S, McDevitt H: Competitive inhibition of antigen presentation in animal models of autoimmune disease. Semin Immunol 1991;3:247–255.
Ravetch JV, Bolland S: IgG Fc receptors. Annu Rev Immunol 2001; 19:275–290.
Tschoetschel U, McCoy KL, Reske-Kunz AB: Augmented antigen presentation by mouse Ia+ T clone cells BK-BI-2.6.04. Imediated by transferrin receptors. Scand. J. Immunol 1996;43:500–506.
McCoy KL, Noone M, Imman JK, Stutzman R: Exogenous antigens internalized through transferrin receptors activate CD4+ T cells. J Immunol 1993;150:1691–1704.
Niebling WL, Pierce SK: Antigen entry into early endosomes is insufficient for mhc class II processing. J Immunol 1993;150:2687–2697.
Mauri D, Wyss-Coray T, Brander C, Pichler WJ: Improved sensitization of antigen-presenting cells with transferrin-bound peptides: advantages in competition for antigen presentation. Cell Immunol 1994;158:59–70.
Mellman I, Turley SJ, Steinman RM: Antigen processing for amateurs and professionals. Trends Cell Biol 1998;8:231–237.
Zaliauskiene L, Kang S, Brouillette C, Lebowitz J, Arani RB, Collawn JF: Down-regulation of cell surface receptors is modulated by polar residues within the transmembrane domains. Mol Biol Cell 2000;11(8): 2643–2655.
Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392:245–252.
Ceppellini R, Frumento G, Ferrara GB, Rosi R, Chersi A, Perrnis B: Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature 1989; 339:392–394.
Zinn KR, Douglas JT, Smyth CA, Liu H-G, Wu Q, Krasnykh VN, Mountz JD, Curriel DT, Mountz JM: Imaging and tissue biodistribution of 99m Tc-labeled adenovirus knob (serotype 5). Gene Ther 1998;5:798–808.
Kearney ER, Pape KA, Loh DY, Jenkins MK: Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994;1:327–339.
Liu H, Rhodes M, Wiest DL, Vignali DA: On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity 2000;13:665–675.
Fulcher DA, Lyons AB, Kom SL, Cook MC, Koleda C, Parish C, Fazekas de St Groth B, Basten A: The fate of self-reactive B cells depends primarity on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med 1996;183:2313–2328.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zaliauskiene, L., Fazio, R.L., Kang, S. et al. Inhibition of T cell responses by transferrin-coupled competitor peptides. Immunol Res 26, 77–85 (2002). https://doi.org/10.1385/IR:26:1-3:077
Issue Date:
DOI: https://doi.org/10.1385/IR:26:1-3:077